Pieris Pharmaceuticals Surges On The Stock Market After Agreement With Genentech
May 26, 2021 at 10:39 AM EDT
During yesterday's session, Pieris Pharmaceuticals (PIRS) soared in the financial markets after reaching a collaboration agreement with Genentech, in an operation that could be valued at $1.4 billion.
